# NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

> **NCT01783600** · PHASE4 · COMPLETED · sponsor: **Flanders Medical Research Program** · enrollment: 100 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** NanoCross .014 balloon catheter

## Key facts

- **NCT ID:** NCT01783600
- **Lead sponsor:** Flanders Medical Research Program
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783600, "NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT01783600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*